Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02454179
Title Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

head and neck squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

Therapies

Pembrolizumab

Acalabrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.